ES2653642T3 - Detección de una secuencia de ácido nucleico diana mediante ensayo sin hibridación dependiente de escisión y extensión de PTO - Google Patents

Detección de una secuencia de ácido nucleico diana mediante ensayo sin hibridación dependiente de escisión y extensión de PTO Download PDF

Info

Publication number: ES2653642T3
Authority: ES; Spain
Prior art keywords: cto; nucleic acid; pto; target nucleic; acid sequence
Prior art date: 2012-12-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

ES13868457.6T

Other languages

English (en)

Spanish (es)

Inventor

Jong Yoon Chun

Young Jo Lee

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Seegene Inc

Original Assignee

Seegene Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-12-27

Filing date

2013-12-27

Publication date

2018-02-08

2013-12-27 Application filed by Seegene Inc filed Critical Seegene Inc

2018-02-08 Application granted granted Critical

2018-02-08 Publication of ES2653642T3 publication Critical patent/ES2653642T3/es

Status Active legal-status Critical Current

2033-12-27 Anticipated expiration legal-status Critical

Links

150000007523 nucleic acids Chemical group 0.000 title claims abstract description 451
238000009396 hybridization Methods 0.000 title claims abstract description 353
108091028043 Nucleic acid sequence Proteins 0.000 title claims abstract description 289
238000003776 cleavage reaction Methods 0.000 title claims abstract description 175
230000007017 scission Effects 0.000 title claims abstract description 168
238000003556 assay Methods 0.000 title claims abstract description 89
230000001419 dependent effect Effects 0.000 title claims abstract description 68
238000001514 detection method Methods 0.000 title claims description 101
239000002773 nucleotide Substances 0.000 claims abstract description 425
125000003729 nucleotide group Chemical group 0.000 claims abstract description 425
239000003550 marker Substances 0.000 claims abstract description 266
239000012634 fragment Substances 0.000 claims abstract description 211
108091034117 Oligonucleotide Proteins 0.000 claims abstract description 195
230000000295 complement effect Effects 0.000 claims abstract description 187
238000002372 labelling Methods 0.000 claims abstract description 177
239000000523 sample Substances 0.000 claims abstract description 164
108020004707 nucleic acids Proteins 0.000 claims abstract description 139
102000039446 nucleic acids Human genes 0.000 claims abstract description 139
230000015572 biosynthetic process Effects 0.000 claims abstract description 126
238000004458 analytical method Methods 0.000 claims abstract description 104
238000000034 method Methods 0.000 claims abstract description 95
230000004927 fusion Effects 0.000 claims abstract description 93
238000006243 chemical reaction Methods 0.000 claims abstract description 85
101710163270 Nuclease Proteins 0.000 claims abstract description 83
230000000694 effects Effects 0.000 claims abstract description 81
102000004190 Enzymes Human genes 0.000 claims abstract description 53
108090000790 Enzymes Proteins 0.000 claims abstract description 53
239000000758 substrate Substances 0.000 claims description 92
239000007787 solid Substances 0.000 claims description 91
230000002452 interceptive effect Effects 0.000 claims description 76
230000002860 competitive effect Effects 0.000 claims description 48
230000005764 inhibitory process Effects 0.000 claims description 31
239000007790 solid phase Substances 0.000 claims description 26
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 19
238000004925 denaturation Methods 0.000 claims description 19
230000036425 denaturation Effects 0.000 claims description 19
239000002585 base Substances 0.000 description 39
108020004414 DNA Proteins 0.000 description 27
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 22
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 22
238000002844 melting Methods 0.000 description 17
230000008018 melting Effects 0.000 description 17
230000003321 amplification Effects 0.000 description 16
238000003199 nucleic acid amplification method Methods 0.000 description 16
238000002493 microarray Methods 0.000 description 15
230000008859 change Effects 0.000 description 13
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 12
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 12
230000000903 blocking effect Effects 0.000 description 12
238000005516 engineering process Methods 0.000 description 12
238000013459 approach Methods 0.000 description 11
239000000203 mixture Substances 0.000 description 11
239000011541 reaction mixture Substances 0.000 description 11
238000011160 research Methods 0.000 description 10
108010006785 Taq Polymerase Proteins 0.000 description 9
229910052799 carbon Inorganic materials 0.000 description 9
241000589596 Thermus Species 0.000 description 8
230000008033 biological extinction Effects 0.000 description 8
230000001965 increasing effect Effects 0.000 description 8
238000003746 solid phase reaction Methods 0.000 description 8
238000012360 testing method Methods 0.000 description 8
241000588652 Neisseria gonorrhoeae Species 0.000 description 7
108091093037 Peptide nucleic acid Proteins 0.000 description 7
241000205188 Thermococcus Species 0.000 description 7
-1 alkane diol Chemical class 0.000 description 7
239000007850 fluorescent dye Substances 0.000 description 7
230000006698 induction Effects 0.000 description 7
125000005647 linker group Chemical group 0.000 description 7
239000007791 liquid phase Substances 0.000 description 7
230000013011 mating Effects 0.000 description 7
108090000623 proteins and genes Proteins 0.000 description 7
125000006850 spacer group Chemical group 0.000 description 7
238000003786 synthesis reaction Methods 0.000 description 7
UDGUGZTYGWUUSG-UHFFFAOYSA-N 4-[4-[[2,5-dimethoxy-4-[(4-nitrophenyl)diazenyl]phenyl]diazenyl]-n-methylanilino]butanoic acid Chemical compound COC=1C=C(N=NC=2C=CC(=CC=2)N(C)CCCC(O)=O)C(OC)=CC=1N=NC1=CC=C([N+]([O-])=O)C=C1 UDGUGZTYGWUUSG-UHFFFAOYSA-N 0.000 description 6
241000589499 Thermus thermophilus Species 0.000 description 6
125000000217 alkyl group Chemical group 0.000 description 6
229960002685 biotin Drugs 0.000 description 6
235000020958 biotin Nutrition 0.000 description 6
239000011616 biotin Substances 0.000 description 6
239000000872 buffer Substances 0.000 description 6
238000007796 conventional method Methods 0.000 description 6
230000007423 decrease Effects 0.000 description 6
238000002866 fluorescence resonance energy transfer Methods 0.000 description 6
239000003269 fluorescent indicator Substances 0.000 description 6
230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 6
230000002401 inhibitory effect Effects 0.000 description 6
229910001629 magnesium chloride Inorganic materials 0.000 description 6
238000012986 modification Methods 0.000 description 6
230000004048 modification Effects 0.000 description 6
238000011897 real-time detection Methods 0.000 description 6
239000000126 substance Substances 0.000 description 6
RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 6
125000003118 aryl group Chemical group 0.000 description 5
230000008901 benefit Effects 0.000 description 5
230000003247 decreasing effect Effects 0.000 description 5
239000000975 dye Substances 0.000 description 5
239000011521 glass Substances 0.000 description 5
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 5
239000010931 gold Substances 0.000 description 5
238000010438 heat treatment Methods 0.000 description 5
238000004519 manufacturing process Methods 0.000 description 5
238000006116 polymerization reaction Methods 0.000 description 5
VGONTNSXDCQUGY-RRKCRQDMSA-N 2'-deoxyinosine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC2=O)=C2N=C1 VGONTNSXDCQUGY-RRKCRQDMSA-N 0.000 description 4
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 4
241000700605 Viruses Species 0.000 description 4
239000012472 biological sample Substances 0.000 description 4
239000003153 chemical reaction reagent Substances 0.000 description 4
VGONTNSXDCQUGY-UHFFFAOYSA-N desoxyinosine Natural products C1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 VGONTNSXDCQUGY-UHFFFAOYSA-N 0.000 description 4
238000006073 displacement reaction Methods 0.000 description 4
238000010494 dissociation reaction Methods 0.000 description 4
230000005593 dissociations Effects 0.000 description 4
230000002255 enzymatic effect Effects 0.000 description 4
238000011156 evaluation Methods 0.000 description 4
229910052751 metal Inorganic materials 0.000 description 4
239000002184 metal Substances 0.000 description 4
230000008569 process Effects 0.000 description 4
230000002829 reductive effect Effects 0.000 description 4
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 4
238000005406 washing Methods 0.000 description 4
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 3
241000207208 Aquifex Species 0.000 description 3
241000522615 Pyrococcus horikoshii Species 0.000 description 3
241001237851 Thermococcus gorgonarius Species 0.000 description 3
241000204666 Thermotoga maritima Species 0.000 description 3
241000204664 Thermotoga neapolitana Species 0.000 description 3
GRRMZXFOOGQMFA-UHFFFAOYSA-J YoYo-1 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=C2N(C3=CC=CC=C3O2)C)=CC=[N+]1CCC[N+](C)(C)CCC[N+](C)(C)CCC[N+](C1=CC=CC=C11)=CC=C1C=C1N(C)C2=CC=CC=C2O1 GRRMZXFOOGQMFA-UHFFFAOYSA-J 0.000 description 3
230000001580 bacterial effect Effects 0.000 description 3
239000002299 complementary DNA Substances 0.000 description 3
238000001816 cooling Methods 0.000 description 3
238000013461 design Methods 0.000 description 3
239000012153 distilled water Substances 0.000 description 3
238000006911 enzymatic reaction Methods 0.000 description 3
230000002349 favourable effect Effects 0.000 description 3
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 3
229910052737 gold Inorganic materials 0.000 description 3
230000003993 interaction Effects 0.000 description 3
238000010369 molecular cloning Methods 0.000 description 3
230000002265 prevention Effects 0.000 description 3
230000037452 priming Effects 0.000 description 3
VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
241000894007 species Species 0.000 description 3
WETFHJRYOTYZFD-YIZRAAEISA-N (2r,3s,5s)-2-(hydroxymethyl)-5-(3-nitropyrrol-1-yl)oxolan-3-ol Chemical compound C1[C@H](O)[C@@H](CO)O[C@@H]1N1C=C([N+]([O-])=O)C=C1 WETFHJRYOTYZFD-YIZRAAEISA-N 0.000 description 2
108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
VGIRNWJSIRVFRT-UHFFFAOYSA-N 2',7'-difluorofluorescein Chemical compound OC(=O)C1=CC=CC=C1C1=C2C=C(F)C(=O)C=C2OC2=CC(O)=C(F)C=C21 VGIRNWJSIRVFRT-UHFFFAOYSA-N 0.000 description 2
OZFPSOBLQZPIAV-UHFFFAOYSA-N 5-nitro-1h-indole Chemical compound [O-][N+](=O)C1=CC=C2NC=CC2=C1 OZFPSOBLQZPIAV-UHFFFAOYSA-N 0.000 description 2
241000726121 Acidianus Species 0.000 description 2
102000002260 Alkaline Phosphatase Human genes 0.000 description 2
108020004774 Alkaline Phosphatase Proteins 0.000 description 2
229910001020 Au alloy Inorganic materials 0.000 description 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
108010017826 DNA Polymerase I Proteins 0.000 description 2
102000004594 DNA Polymerase I Human genes 0.000 description 2
241000196324 Embryophyta Species 0.000 description 2
102100031780 Endonuclease Human genes 0.000 description 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
241000233866 Fungi Species 0.000 description 2
241000508310 Meiothermus chliarophilus Species 0.000 description 2
241000589496 Meiothermus ruber Species 0.000 description 2
241000508289 Meiothermus silvanus Species 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
102100029684 Methylenetetrahydrofolate reductase Human genes 0.000 description 2
102000003992 Peroxidases Human genes 0.000 description 2
108091036407 Polyadenylation Proteins 0.000 description 2
241001148023 Pyrococcus abyssi Species 0.000 description 2
241000205192 Pyrococcus woesei Species 0.000 description 2
241000204670 Pyrodictium occultum Species 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
108010090804 Streptavidin Proteins 0.000 description 2
241000205180 Thermococcus litoralis Species 0.000 description 2
241000206213 Thermosipho africanus Species 0.000 description 2
241000015345 Thermus antranikianii Species 0.000 description 2
241000589500 Thermus aquaticus Species 0.000 description 2
241000589501 Thermus caldophilus Species 0.000 description 2
241000589498 Thermus filiformis Species 0.000 description 2
241000015334 Thermus igniterrae Species 0.000 description 2
241000557726 Thermus oshimai Species 0.000 description 2
241001522143 Thermus scotoductus Species 0.000 description 2
MZZINWWGSYUHGU-UHFFFAOYSA-J ToTo-1 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=C2N(C3=CC=CC=C3S2)C)=CC=[N+]1CCC[N+](C)(C)CCC[N+](C)(C)CCC[N+](C1=CC=CC=C11)=CC=C1C=C1N(C)C2=CC=CC=C2S1 MZZINWWGSYUHGU-UHFFFAOYSA-J 0.000 description 2
125000003277 amino group Chemical group 0.000 description 2
210000003050 axon Anatomy 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
230000001186 cumulative effect Effects 0.000 description 2
238000012217 deletion Methods 0.000 description 2
230000037430 deletion Effects 0.000 description 2
239000005546 dideoxynucleotide Substances 0.000 description 2
230000003292 diminished effect Effects 0.000 description 2
239000000284 extract Substances 0.000 description 2
239000012530 fluid Substances 0.000 description 2
238000001917 fluorescence detection Methods 0.000 description 2
238000011065 in-situ storage Methods 0.000 description 2
238000003780 insertion Methods 0.000 description 2
230000037431 insertion Effects 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
230000001404 mediated effect Effects 0.000 description 2
238000011880 melting curve analysis Methods 0.000 description 2
108020004999 messenger RNA Proteins 0.000 description 2
239000003068 molecular probe Substances 0.000 description 2
230000035772 mutation Effects 0.000 description 2
229940046166 oligodeoxynucleotide Drugs 0.000 description 2
230000036961 partial effect Effects 0.000 description 2
108040007629 peroxidase activity proteins Proteins 0.000 description 2
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 2
210000002381 plasma Anatomy 0.000 description 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
238000010839 reverse transcription Methods 0.000 description 2
230000035945 sensitivity Effects 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
230000011664 signaling Effects 0.000 description 2
235000012239 silicon dioxide Nutrition 0.000 description 2
108010068698 spleen exonuclease Proteins 0.000 description 2
238000006467 substitution reaction Methods 0.000 description 2
ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
NCMVOABPESMRCP-SHYZEUOFSA-N 2'-deoxycytosine 5'-monophosphate Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)C1 NCMVOABPESMRCP-SHYZEUOFSA-N 0.000 description 1
WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
241000567139 Aeropyrum pernix Species 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
108091093088 Amplicon Proteins 0.000 description 1
JBRZTFJDHDCESZ-UHFFFAOYSA-N AsGa Chemical compound [As]#[Ga] JBRZTFJDHDCESZ-UHFFFAOYSA-N 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
241000212384 Bifora Species 0.000 description 1
101150003340 CYP2C19 gene Proteins 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
208000005623 Carcinogenesis Diseases 0.000 description 1
229910000881 Cu alloy Inorganic materials 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
108010042407 Endonucleases Proteins 0.000 description 1
241000701832 Enterobacteria phage T3 Species 0.000 description 1
241000991587 Enterovirus C Species 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
229910001218 Gallium arsenide Inorganic materials 0.000 description 1
241000282412 Homo Species 0.000 description 1
101000587058 Homo sapiens Methylenetetrahydrofolate reductase Proteins 0.000 description 1
241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
229930010555 Inosine Natural products 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
241000204641 Methanopyrus kandleri Species 0.000 description 1
241000203373 Methanotorris igneus Species 0.000 description 1
108010030837 Methylenetetrahydrofolate Reductase (NADPH2) Proteins 0.000 description 1
108060004795 Methyltransferase Proteins 0.000 description 1
NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
238000012408 PCR amplification Methods 0.000 description 1
108010053210 Phycocyanin Proteins 0.000 description 1
108010004729 Phycoerythrin Proteins 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
241000736843 Pyrobaculum aerophilum Species 0.000 description 1
241000205156 Pyrococcus furiosus Species 0.000 description 1
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
108091028664 Ribonucleotide Proteins 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
229920002684 Sepharose Polymers 0.000 description 1
241000580858 Simian-Human immunodeficiency virus Species 0.000 description 1
241000205091 Sulfolobus solfataricus Species 0.000 description 1
241000529868 Thermococcus zilligii Species 0.000 description 1
241000204315 Thermosipho <sea snail> Species 0.000 description 1
241000204652 Thermotoga Species 0.000 description 1
HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
241000726445 Viroids Species 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000009471 action Effects 0.000 description 1
239000003570 air Substances 0.000 description 1
239000003513 alkali Substances 0.000 description 1
125000002947 alkylene group Chemical group 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
150000001412 amines Chemical group 0.000 description 1
230000003466 anti-cipated effect Effects 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
102000023732 binding proteins Human genes 0.000 description 1
108091008324 binding proteins Proteins 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
DEGAKNSWVGKMLS-UHFFFAOYSA-N calcein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(O)=O)CC(O)=O)=C(O)C=C1OC1=C2C=C(CN(CC(O)=O)CC(=O)O)C(O)=C1 DEGAKNSWVGKMLS-UHFFFAOYSA-N 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000011575 calcium Substances 0.000 description 1
IDMLRIMDYVWWRJ-UHFFFAOYSA-N calcium crimson Chemical compound CC(=O)OCOC(=O)CN(CC(=O)OCOC(C)=O)C1=CC=CC=C1OCCOC1=CC(NS(=O)(=O)C=2C=C(C(C=3C4=CC=5CCCN6CCCC(C=56)=C4OC4=C5C6=[N+](CCC5)CCCC6=CC4=3)=CC=2)S([O-])(=O)=O)=CC=C1N(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O IDMLRIMDYVWWRJ-UHFFFAOYSA-N 0.000 description 1
NMUGYJRMGWBCPU-UHFFFAOYSA-N calcium orange Chemical compound C=12C=CC(=[N+](C)C)C=C2OC2=CC(N(C)C)=CC=C2C=1C(C(=C1)C([O-])=O)=CC=C1NC(=S)NC(C=1)=CC=C(N(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O)C=1OCCOC1=CC=CC=C1N(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O NMUGYJRMGWBCPU-UHFFFAOYSA-N 0.000 description 1
230000036952 cancer formation Effects 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
125000004432 carbon atom Chemical group C* 0.000 description 1
229910021393 carbon nanotube Inorganic materials 0.000 description 1
239000002041 carbon nanotube Substances 0.000 description 1
231100000504 carcinogenesis Toxicity 0.000 description 1
210000004027 cell Anatomy 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
239000000919 ceramic Substances 0.000 description 1
210000001175 cerebrospinal fluid Anatomy 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
238000003759 clinical diagnosis Methods 0.000 description 1
229910052681 coesite Inorganic materials 0.000 description 1
239000000084 colloidal system Substances 0.000 description 1
239000000470 constituent Substances 0.000 description 1
229910052906 cristobalite Inorganic materials 0.000 description 1
238000013211 curve analysis Methods 0.000 description 1
GYOZYWVXFNDGLU-XLPZGREQSA-N dTMP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)C1 GYOZYWVXFNDGLU-XLPZGREQSA-N 0.000 description 1
230000006735 deficit Effects 0.000 description 1
KHWCHTKSEGGWEX-UHFFFAOYSA-N deoxyadenylic acid Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(O)=O)O1 KHWCHTKSEGGWEX-UHFFFAOYSA-N 0.000 description 1
239000005547 deoxyribonucleotide Substances 0.000 description 1
125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
229910000397 disodium phosphate Inorganic materials 0.000 description 1
235000019800 disodium phosphate Nutrition 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
230000009977 dual effect Effects 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
210000001508 eye Anatomy 0.000 description 1
210000003608 fece Anatomy 0.000 description 1
239000000835 fiber Substances 0.000 description 1
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
238000012921 fluorescence analysis Methods 0.000 description 1
238000001506 fluorescence spectroscopy Methods 0.000 description 1
238000002189 fluorescence spectrum Methods 0.000 description 1
235000013305 food Nutrition 0.000 description 1
238000007429 general method Methods 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
238000003205 genotyping method Methods 0.000 description 1
229910052732 germanium Inorganic materials 0.000 description 1
GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 1
208000006454 hepatitis Diseases 0.000 description 1
231100000283 hepatitis Toxicity 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
238000007641 inkjet printing Methods 0.000 description 1
229960003786 inosine Drugs 0.000 description 1
238000009830 intercalation Methods 0.000 description 1
230000002687 intercalation Effects 0.000 description 1
210000002751 lymph Anatomy 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
NGCVJRFIBJVSFI-UHFFFAOYSA-I magnesium green Chemical compound [K+].[K+].[K+].[K+].[K+].C1=C(N(CC([O-])=O)CC([O-])=O)C(OCC(=O)[O-])=CC(NC(=O)C=2C=C3C(C4(C5=CC(Cl)=C([O-])C=C5OC5=CC([O-])=C(Cl)C=C54)OC3=O)=CC=2)=C1 NGCVJRFIBJVSFI-UHFFFAOYSA-I 0.000 description 1
239000000155 melt Substances 0.000 description 1
239000012528 membrane Substances 0.000 description 1
229910044991 metal oxide Inorganic materials 0.000 description 1
150000004706 metal oxides Chemical class 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
125000005341 metaphosphate group Chemical group 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
239000008267 milk Substances 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
239000013642 negative control Substances 0.000 description 1
VOFUROIFQGPCGE-UHFFFAOYSA-N nile red Chemical compound C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4OC3=CC(=O)C2=C1 VOFUROIFQGPCGE-UHFFFAOYSA-N 0.000 description 1
238000007899 nucleic acid hybridization Methods 0.000 description 1
238000001668 nucleic acid synthesis Methods 0.000 description 1
230000001293 nucleolytic effect Effects 0.000 description 1
239000002777 nucleoside Substances 0.000 description 1
125000003835 nucleoside group Chemical group 0.000 description 1
229960002378 oftasceine Drugs 0.000 description 1
238000005457 optimization Methods 0.000 description 1
210000002741 palatine tonsil Anatomy 0.000 description 1
244000045947 parasite Species 0.000 description 1
239000002245 particle Substances 0.000 description 1
244000052769 pathogen Species 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
150000008298 phosphoramidates Chemical class 0.000 description 1
238000000206 photolithography Methods 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
239000012985 polymerization agent Substances 0.000 description 1
108091033319 polynucleotide Proteins 0.000 description 1
239000002157 polynucleotide Substances 0.000 description 1
102000040430 polynucleotide Human genes 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
239000013641 positive control Substances 0.000 description 1
239000001103 potassium chloride Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
230000000750 progressive effect Effects 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
INCIMLINXXICKS-UHFFFAOYSA-M pyronin Y Chemical compound [Cl-].C1=CC(=[N+](C)C)C=C2OC3=CC(N(C)C)=CC=C3C=C21 INCIMLINXXICKS-UHFFFAOYSA-M 0.000 description 1
238000004445 quantitative analysis Methods 0.000 description 1
239000010453 quartz Substances 0.000 description 1
230000000241 respiratory effect Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
MYIOYATURDILJN-UHFFFAOYSA-N rhodamine 110 Chemical compound [Cl-].C=12C=CC(N)=CC2=[O+]C2=CC(N)=CC=C2C=1C1=CC=CC=C1C(O)=O MYIOYATURDILJN-UHFFFAOYSA-N 0.000 description 1
TUFFYSFVSYUHPA-UHFFFAOYSA-M rhodamine 123 Chemical compound [Cl-].COC(=O)C1=CC=CC=C1C1=C(C=CC(N)=C2)C2=[O+]C2=C1C=CC(N)=C2 TUFFYSFVSYUHPA-UHFFFAOYSA-M 0.000 description 1
229940043267 rhodamine b Drugs 0.000 description 1
239000001022 rhodamine dye Substances 0.000 description 1
239000002336 ribonucleotide Substances 0.000 description 1
125000002652 ribonucleotide group Chemical group 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
JRPHGDYSKGJTKZ-UHFFFAOYSA-N selenophosphoric acid Chemical compound OP(O)([SeH])=O JRPHGDYSKGJTKZ-UHFFFAOYSA-N 0.000 description 1
210000000582 semen Anatomy 0.000 description 1
239000004065 semiconductor Substances 0.000 description 1
230000007727 signaling mechanism Effects 0.000 description 1
239000010703 silicon Substances 0.000 description 1
229910052710 silicon Inorganic materials 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000002689 soil Substances 0.000 description 1
239000000243 solution Substances 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
230000007480 spreading Effects 0.000 description 1
238000003892 spreading Methods 0.000 description 1
239000007858 starting material Substances 0.000 description 1
229910052682 stishovite Inorganic materials 0.000 description 1
JGVWCANSWKRBCS-UHFFFAOYSA-N tetramethylrhodamine thiocyanate Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=C(SC#N)C=C1C(O)=O JGVWCANSWKRBCS-UHFFFAOYSA-N 0.000 description 1
MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
ACOJCCLIDPZYJC-UHFFFAOYSA-M thiazole orange Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1.C1=CC=C2C(C=C3N(C4=CC=CC=C4S3)C)=CC=[N+](C)C2=C1 ACOJCCLIDPZYJC-UHFFFAOYSA-M 0.000 description 1
150000003573 thiols Chemical group 0.000 description 1
230000005945 translocation Effects 0.000 description 1
229910052905 tridymite Inorganic materials 0.000 description 1
239000001226 triphosphate Substances 0.000 description 1
241001529453 unidentified herpesvirus Species 0.000 description 1
241000712461 unidentified influenza virus Species 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
238000012800 visualization Methods 0.000 description 1
239000002699 waste material Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6823—Release of bound markers
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
Biochemistry (AREA)
Physics & Mathematics (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Analytical Chemistry (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Chemical Kinetics & Catalysis (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

ES13868457.6T 2012-12-27 2013-12-27 Detección de una secuencia de ácido nucleico diana mediante ensayo sin hibridación dependiente de escisión y extensión de PTO Active ES2653642T3 (es)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
KR20120154834		2012-12-27
KR20120154834		2012-12-27
KR20130008580		2013-01-25
KR20130008580		2013-01-25
KR20130034670		2013-03-29
KR20130034670		2013-03-29
PCT/KR2013/012312 WO2014104818A1 (en)	2012-12-27	2013-12-27	Detection of target nucleic acid sequence by pto cleavage and extension-dependent non-hybridization assay

Publications (1)

Publication Number	Publication Date
ES2653642T3 true ES2653642T3 (es)	2018-02-08

Family

ID=51021756

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ES13868457.6T Active ES2653642T3 (es)	2012-12-27	2013-12-27	Detección de una secuencia de ácido nucleico diana mediante ensayo sin hibridación dependiente de escisión y extensión de PTO

Country Status (12)

Country	Link
US (2)	US9783845B2 (2)
EP (1)	EP2943586B1 (2)
JP (1)	JP6178430B2 (2)
KR (1)	KR101760267B1 (2)
CN (1)	CN104903465B (2)
AU (1)	AU2013371128B2 (2)
BR (1)	BR112015014152B1 (2)
CA (1)	CA2896213C (2)
ES (1)	ES2653642T3 (2)
MX (1)	MX361191B (2)
RU (1)	RU2620958C2 (2)
WO (1)	WO2014104818A1 (2)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2017213458A1 (en)	2016-06-10	2017-12-14	Seegene, Inc.	Methods for preparing tagging oligonucleotides
KR102301305B1 (ko)	2016-06-30	2021-09-13	주식회사 씨젠	핵산 증폭용 튜브 및 핵산 증폭용 반응 용기
EP3523452B1 (en)	2016-10-06	2026-04-15	Seegene, Inc.	Methods for preparing oligonucleotides for detecting target nucleic acid molecules in samples
CA3049833A1 (en) *	2016-12-23	2018-06-28	Albert-Ludwigs-Universitat Freiburg	Two-piece mediator probe
IL319189A (en)	2016-12-29	2025-04-01	Seegene Inc	Method for reducing primer dimer formation and increasing amplification efficiency
CN110475871B (zh)	2017-03-28	2024-04-12	Seegene株式会社	用于确定靶核酸序列的存在的分析信号
CN108823287B (zh)	2017-04-28	2019-04-12	厦门大学	一种检测靶核酸序列的方法
CN107236815A (zh) *	2017-07-18	2017-10-10	江西贤聚景欣医药生物科技有限公司	用于靶核酸序列检测的多重淬灭荧光探针及方法
WO2019045532A2 (en)	2017-08-31	2019-03-07	Seegene, Inc.	EVALUATION OF COMPONENT PERFORMANCE USING A PAIR OF DIMER FORMER PRIMERS
KR102345601B1 (ko)	2017-09-29	2021-12-30	주식회사 씨젠	Pto 절단 및 연장-의존적 연장 분석에 의한 타겟 핵산 서열의 검출
EP3735476B1 (en)	2018-01-05	2023-08-23	Seegene, Inc.	Method for determining the presence or absence of m. tuberculosis, m. bovis and m. bovis bcg in a sample
KR102464501B1 (ko)	2018-04-20	2022-11-17	주식회사 씨젠	샘플 내 복수의 타겟 핵산 서열의 검출을 위한 방법 및 장치
WO2020122679A1 (en)	2018-12-14	2020-06-18	Seegene, Inc.	Method for detecting a target analyte in a sample using an s-shaped function for a slope data set
US20220298555A1 (en) *	2018-12-20	2022-09-22	Roche Molecular Systems, Inc.	Detection of target nucleic acid by solid-phase molography
EP4301880A4 (en)	2021-03-05	2025-06-18	Seegene, Inc.	METHOD FOR DETECTING SARS-COV-2 MUTATIONS
KR20240058112A (ko) *	2021-09-17	2024-05-03	주식회사 씨젠	합성 비자연 염기를 포함하는 태그 올리고뉴클레오타이드를 이용한 타겟 핵산 서열의 검출
EP4265734A1 (de) *	2022-04-22	2023-10-25	Hahn-Schickard-Gesellschaft für angewandte Forschung e.V.	Nukleinsäurenachweis in einer pcr mittels eines zielsequenz-unspezifischem modularer reporterkomplexes
US20250340928A1 (en) *	2022-04-22	2025-11-06	Albert-Ludwigs-Universität Freiburg	Nucleic acid detection in a pcr by means of a target-sequence-unspecific modular reporter complex
KR20250086619A (ko)	2022-10-14	2025-06-13	주식회사 씨젠	상이한 tm 값을 가지는 2개의 프로브를 이용하여 샘플 내 타겟 핵산을 검출하는 방법
EP4372100A1 (en) *	2022-11-15	2024-05-22	Stilla Technologies	Data analysis method for multiplex digital pcr using color-combination
EP4621068A1 (en)	2022-11-16	2025-09-24	Seegene, Inc.	Detection of target nucleic acid by quenching-pto cleavage and extension (q-ptoce) assay
WO2025005717A1 (ko) *	2023-06-30	2025-01-02	주식회사 씨젠	Hto 절단 및 자기-연장 어세이에 의해 샘플 내의 타겟 핵산을 검출하는 방법

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5210015A (en)	1990-08-06	1993-05-11	Hoffman-La Roche Inc.	Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US5994069A (en)	1996-01-24	1999-11-30	Third Wave Technologies, Inc.	Detection of nucleic acids by multiple sequential invasive cleavages
US5541311A (en)	1992-12-07	1996-07-30	Third Wave Technologies, Inc.	Nucleic acid encoding synthesis-deficient thermostable DNA polymerase
US5538848A (en)	1994-11-16	1996-07-23	Applied Biosystems Division, Perkin-Elmer Corp.	Method for detecting nucleic acid amplification using self-quenching fluorescence probe
GB9812768D0 (en)	1998-06-13	1998-08-12	Zeneca Ltd	Methods
US6893819B1 (en)	2000-11-21	2005-05-17	Stratagene California	Methods for detection of a nucleic acid by sequential amplification
US7381532B2 (en)	1999-10-29	2008-06-03	Stratagene California	Compositions and methods for the detection of a nucleic acid using a cleavage reaction
US7601497B2 (en) *	2000-06-15	2009-10-13	Qiagen Gaithersburg, Inc.	Detection of nucleic acids by target-specific hybrid capture method
US7309573B2 (en)	2000-11-21	2007-12-18	Stratagene California	Methods for detection of a nucleic acid by sequential amplification
KR20020063359A (ko)	2001-01-27	2002-08-03	일렉트론 바이오 (주)	핵산 및 올리거뉴클레오티드의 상보적 이중결합의 특정서열에 특이적으로 반응하는 절단기법을 이용한 핵산 혼성분석 방법 및 장치
GB0205455D0 (en) *	2002-03-07	2002-04-24	Molecular Sensing Plc	Nucleic acid probes, their synthesis and use
EP1689764B1 (en)	2003-11-19	2013-01-02	AlleLogic Biosciences Corporation	Oligonucleotides labeled with a plurality of fluorophores
EP2046989B1 (en) *	2006-07-17	2013-03-20	Brandeis University	Specialized oligonucleotides and their use in nucleic acid amplification and detection
US20090023151A1 (en) *	2006-08-30	2009-01-22	Dawson Elliott P	Method For The Labeling And Detection Of Small Polynucleotides
WO2008083261A1 (en)	2006-12-29	2008-07-10	Applera Corporation	Systems and methods for detecting nucleic acids
MX352460B (es) *	2011-01-11	2017-11-24	Seegene Inc	Detección de secuencias de ácido nucleico objetivo mediante ensayo de escisión y extensión del pto.
JP5852222B2 (ja) *	2011-03-29	2016-02-03	シージーンアイエヌシー	Ｐｔｏ切断及び延長−依存的切断によるターゲット核酸配列の検出
MX342067B (es) *	2011-05-04	2016-09-09	Seegene Inc	Detección de secuencias de ácido nucleico objetivo por desdoblamiento e hibridización de oligonucleótido de sonda.

2013
- 2013-12-27 EP EP13868457.6A patent/EP2943586B1/en active Active
- 2013-12-27 AU AU2013371128A patent/AU2013371128B2/en active Active
- 2013-12-27 ES ES13868457.6T patent/ES2653642T3/es active Active
- 2013-12-27 MX MX2015008494A patent/MX361191B/es active IP Right Grant
- 2013-12-27 BR BR112015014152-8A patent/BR112015014152B1/pt active IP Right Grant
- 2013-12-27 WO PCT/KR2013/012312 patent/WO2014104818A1/en not_active Ceased
- 2013-12-27 KR KR1020157017974A patent/KR101760267B1/ko active Active
- 2013-12-27 CA CA2896213A patent/CA2896213C/en active Active
- 2013-12-27 US US14/655,847 patent/US9783845B2/en active Active
- 2013-12-27 JP JP2015550327A patent/JP6178430B2/ja active Active
- 2013-12-27 RU RU2015130335A patent/RU2620958C2/ru active
- 2013-12-27 CN CN201380068241.3A patent/CN104903465B/zh active Active
2017
- 2017-09-07 US US15/697,617 patent/US20180057869A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP2943586A4 (en)	2016-09-28
WO2014104818A1 (en)	2014-07-03
KR101760267B1 (ko)	2017-07-24
CN104903465B (zh)	2017-04-26
EP2943586B1 (en)	2017-09-20
US20160060690A1 (en)	2016-03-03
JP6178430B2 (ja)	2017-08-09
CA2896213C (en)	2018-12-11
EP2943586A1 (en)	2015-11-18
JP2016502861A (ja)	2016-02-01
MX2015008494A (es)	2015-09-10
AU2013371128A1 (en)	2015-08-13
US9783845B2 (en)	2017-10-10
BR112015014152A2 (2)	2017-08-22
KR20150093766A (ko)	2015-08-18
RU2015130335A (ru)	2017-01-30
RU2620958C2 (ru)	2017-05-30
US20180057869A1 (en)	2018-03-01
MX361191B (es)	2018-11-29
AU2013371128B2 (en)	2017-08-10
CN104903465A (zh)	2015-09-09
BR112015014152B1 (pt)	2023-01-24
CA2896213A1 (en)	2014-07-03

Publication	Publication Date	Title
ES2653642T3 (es)	2018-02-08	Detección de una secuencia de ácido nucleico diana mediante ensayo sin hibridación dependiente de escisión y extensión de PTO
US10731203B2 (en)	2020-08-04	Detection of target nucleic acid sequence by PTO cleavage and extension-dependent signaling oligonucleotide hybridization assay
ES2629759T3 (es)	2017-08-14	Detección de secuencias de ácidos nucleicos diana mediante un ensayo de escisión y extensión de PTO
ES2657906T3 (es)	2018-03-07	Detección de secuencias de ácidos nucleicos objetivo mediante una escisión y una hibridación de un PO
ES2669244T3 (es)	2018-05-24	Detección de variación de nucleótidos en una secuencia de ácido nucleico diana mediante escisión CTO y ensayo de extensión
JP6096885B2 (ja)	2017-03-15	ＰＴＯ切断及び伸長依存的なシグナリングオリゴヌクレオチド切断を用いたターゲット核酸配列の検出｛ＤｅｔｅｃｔｉｏｎｏｆＴａｒｇｅｔＮｕｃｌｅｉｃＡｃｉｄＳｅｑｕｅｎｃｅｂｙＰＴＯＣｌｅａｖａｇｅａｎｄＥｘｔｅｎｓｉｏｎ−ＤｅｐｅｎｄｅｎｔＳｉｇｎａｌｉｎｇＯｌｉｇｏｎｕｃｌｅｏｔｉｄｅＣｌｅａｖａｇｅ｝
US20160258007A1 (en)	2016-09-08	Detection of target nucleic acid sequence on solid phase by pto cleavage and extension using hcto assay
AU2015203677B2 (en)	2016-06-23	Detection of Target Nucleic Acid Sequences by PTO Cleavage and Extension
RU2588457C2 (ru)	2016-06-27	Определение целевых нуклеиновокислотных последовательностей путем расщепления зондирующего олигонуклеотида и гибридизации
WO2013187628A1 (en)	2013-12-19	Detection of target nucleic acid sequence by pto cleavage and extension-dependent transcription